corridor consultations: CARDIOLOGY

The systolic hypertension in the elderly (SHEP) and MRFIT trials made it very clear that both systolic and diastolic levels are equally important in determining a patient's risk for cardiovascular events and in deciding on the need for drug treatment. Treating a patient with an elevated systoli...

Full description

Saved in:
Bibliographic Details
Published inPatient Care Vol. 16; no. 10; p. 19
Main Author Burgess, John H
Format Trade Publication Article
LanguageEnglish
Published Mississauga Rogers Media Inc 01.10.2005
Subjects
Antibiotics
Blood pressure
Cardiovascular disease
Cholesterol
Congenital diseases
Disease management
Disease prevention
Endocarditis
Exercise
Heart
High density lipoprotein
Hypertension
Ischemia
Medicine
Mitral valve prolapse
Patients
Statins
Vitamin B
Canada
Online AccessGet full text

Cover

More Information
Summary:The systolic hypertension in the elderly (SHEP) and MRFIT trials made it very clear that both systolic and diastolic levels are equally important in determining a patient's risk for cardiovascular events and in deciding on the need for drug treatment. Treating a patient with an elevated systolic level even when the diastolic is low is important for preventing stroke and managing heart failure in the elderly.
ISSN:0845-065X